[Other] Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735

leonardosilva Post time 2026-10-19 07:16:38 | Show all posts |Read mode
This post will be closed automatically in 2026-10-22 07:16
Reward20points

journalㄩJournal of Clinical Oncology

AuthorsㄩStephen Jones; Frankie Ann Holmes; Joyce O'Shaughnessy; Joanne L. Blum; Svetislava J. Vukelja; Kristi J. McIntyre; John E. Pippen; James H. Bordelon; Robert L. Kirby; John Sandbach; William J. Hyman; Donald A. Richards; Robert G. Mennel; Kristi A. Boehm; Wally G. Meyer; Lina Asmar; Daniel Mackey; Stefan Riedel; Hyman Muss; Michael A. Savin

Published dateㄩ2009-3-10

DOIㄩ10.1200/jco.2008.18.4028

PDF linkㄩhttps://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.18.4028

Article linkㄩhttps://doi.org/10.1200/jco.2008.18.4028

Article SourceㄩAmerican Society of Clinical Oncology (ASCO)﹝


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
jakir_ete_ruet Post time 2026-10-19 07:16:39 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    1420


Daily Top Contributors

Return to the list